Faculty Guide to Commercialization

guidecover (320x240)
Faculty Guide to Commercialization

The purpose of this Faculty Guide to Commercialization is to provide a resource that describes key elements of the commercialization process and to provide a description of the teams and individuals involved in this process so that members of the Baylor College of Medicine research community can understand who does what, why they do it, and how they can serve you.

If you have questions about the licensing process, or questions about whether a discovery in your lab might be patentable, or if you’re interested in pursuing commercialization grant funding, this guide can help you find answers.

You may download the Faculty Guide to Commercialization in pdf. If you would like to request a printed copy of the guide, please email blg@bcm.edu.

The Commercialization Process Flowchart

This one-page flowchart demonstrates the activity of our office from receipt of a disclosure through the decision process regarding that disclosure. The end goal is to license the technology to an industry partner. A patent may be applied for if it is necessary to interest a licensee. Often, it is not necessary to patent a technology in order to license it. 

Initiate the Technology Disclosure Process

To begin the process, log in and complete the online technology disclosure form and submit it to Baylor Licensing Group.

Policy on Patents & Other Intellectual Property

Baylor College of Medicine, like other employers, owns all intellectual property owned by its employees. Details are found in the Baylor Policy on Patents and Other Intellectual Property (BCM Intranet login required).

Inventors should be aware that any public disclosure, through publication or other non-confidential presentation of the technology (including meeting abstracts, poster presentations, and seminars) made prior to filing a U.S. patent, will result in the immediate loss of foreign patent rights. BLG encourages faculty members to disclose technologies early in the development process. An early review will permit the protection of valuable patent rights if that is deemed necessary.